Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-21

FDA Approved: CABERGOLINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for cabergoline submitted by Mylan Pharmaceuticals Inc., confirming additional approval activity for this drug. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

SUPPL AP for CABERGOLINE (CABERGOLINE)